Govt Promotes R&D in Pharma Medtech Sector with AI Integration
26 Mar 2025 CW Team
The Department of Pharmaceuticals (DoP) has launched initiatives to enhance research and development (R&D) in the pharmaceutical sector, particularly in artificial intelligence (AI) and machine learning, through the Scheme for Promotion of Research and Innovation in the Pharma Medtech Sector. As part of these efforts, the National Institutes of Pharmaceutical Education and Research (NIPER), under DoP, have incorporated AI and blockchain technology into their academic curriculum and are training students in AI-based tools to strengthen human resource capabilities in the sector.
Additionally, the Department of Biotechnology is supporting AI-driven research in biotechnology, with a focus on healthcare and agriculture, to leverage emerging technologies for these critical industries. The Pharmaceuticals and Medical Devices Bureau of India, in collaboration with the Centre for Development of Advanced Computing, has also initiated a pilot project to assess the feasibility of a blockchain-based track-and-trace system for the Pradhan Mantri Bhartiya Janaushadhi Pariyojana.
This information was provided by Union Minister of State for Chemicals and Fertilisers, Smt. Anupriya Patel, in a written reply to a question in the Rajya Sabha.
(PIB)